According to a research report titled ‘Global Biological & Chemical Indicators Market Size study, by Sterilization Type (Thermal Sterilization, Chemical Sterilization, Radiation Sterilization) by Indicator Class (Biological Indicators, Chemical Indicators, Enzyme Indicators) by Packaging Form (Self-Contained BI, Spore Suspension BI, Strip and Disc BI, Strip and Disc CI, Others) by End User(Biopharma Industry, Hospitals, Clinics, Ambulatory Surgical Centers, Diagnostic Labs, Research Labs) and Regional Forecasts 2020-2027’, available with Market Study Report, global biological & chemical indicators market was valued at USD 372.21 million in 2019 and is projected to grow at 7.29% CAGR, amassing USD 653.52 million by the year 2027.
 

As per report findings, strict GMP (good manufacturing practice) norms regarding quality control and lab testing of finished products is driving pharmaceutical and biotech companies to adopt sterilization practices, hence boosting the growth of global biological and chemical indicators market.
 

Request sample copy of this Report: https://www.marketstudyreport.com/request-a-sample/3002246/
 

Additionally, high risk of infection during surgeries and other medical procedures, along with increased incidences of hospital acquired infections (HAI) are augmenting the demand for biological & chemical indicators for sterilization purpose.
 

Despite the lucrative returns, longer processing time and other inconveniences will hamper market growth in the ensuing years.
 

By sterilization type, the market is classified into chemical, radiation, and thermal. As per packaging form, the industry is arrayed into self-contained BI, strip & disc BI, spore suspension BI, strip & disc CI and others.
 

Based on indicator class, biological, chemical, and enzyme indicators contribute to global biological & chemical indicators market valuation. Of these, enzymatic indicators are gaining substantial traction, due to advantages such as minimal financial loss, rapid delivery of results, and reduced risk.
 

Moving on to end user spectrum, worldwide biological & chemical indicators industry is categorized into biopharma industry, ambulatory surgical centers, hospitals, diagnostic labs, clinics, and research labs.
 

Considering the regional outlook, North America accounted for a significant market share in the recent past, owing to increasing number of surgical procedures as well as prevalence of hospital acquired infections (HAI).
 

However, Asia Pacific biological & chemical indicators industry is anticipated to exhibit the highest CAGR during the forecast period, owing to factors such as rising infectious ailments and associated cases.
 

Key contenders in global biological & chemical indicators market are Protak Scientific Ltd., 3M Company, Getinge AB, Steris Corporation, Mesa Laboratories Inc., Crosstex International Inc., gke GmbH, McKesson Medical-Surgical Inc., Propper Manufacturing Co. Inc., and Thermo Fisher Scientific Inc.